Antibody responses against lytic and latent Kaposi sarcoma (KS)-associated herpesvirus antigens were investigated in patients with KS, multicentric Castleman disease (MCD), and primary effusion lymphoma. Antibodies against the lytic antigen K8.1 were 5-fold higher in patients with MCD than those with KS, whereas antibodies to the sum of latent antigens v-cyclin and LANA were 27-fold higher in patients with KS, compared with patients with MCD ( ). The P ! .001 sum of anti-v-cyclin and anti-LANA antibody titers discriminated patients with KS from those with MCD and KS with 93% sensitivity and 83% specificity. These results suggest that antibody responses to lytic and latent KS-associated herpesvirus antigens differ in these diseases.
teins [1, 2] . KSHV has a 170.5-kb genome encoding ∼90 gene products and containing a number of pirated genes involved in cell proliferation, angiogenesis, and evasion of the immune system [3] . KSHV is also the causative agent of 2 rare B cell lymphoproliferative disorders, primary effusion lymphoma (PEL) and multicentric Castleman disease (MCD), that occur primarily in patients infected with human immunodeficiency virus. PEL is characterized by its tendency to develop in body cavities, such as pleural or peritoneal spaces [4] [5] [6] . MCD is characterized clinically by fevers, wasting, hypoalbuminemia, and cytopenias that result from overproduction of virus-encoded and human-encoded cytokines, especially interleukin-6 (IL-6) [7, 8] .
Like other herpesviruses, KSHV has 2 phases of gene expression, latent and lytic. In KS, a majority of KSHV-infected spindle cells express only latent genes, whereas a small percentage express lytic genes [9] [10] [11] . By contrast, in MCD a substantial percentage of cells express lytic KSHV genes, including a virally encoded IL-6. The majority of PEL cells express KSHV latent genes but, in addition, can show limited expression of certain lytic genes [9] [10] [11] .
Luciferase immunoprecipitation systems (LIPS) is a powerful new method to quantitatively measure antibody responses to a wide range of infectious agents. LIPS screening of a panel of KSHV antigens identified v-cyclin as a useful diagnostic antigen that, along with 3 other antigens, provided high sensitivity and specificity for the differentiation between patients with KS and blood bank donor controls [12] . Given the differential expression of KSHV lytic and latent proteins in patients with KS, PEL, and MCD, we hypothesized that different antibody profiles to KSHV antigens detected by LIPS might distinguish these diseases.
Methods. Serum samples were from patients or volunteers under institutional review board-approved protocols at the Na- [12] . The LIPS assay was performed at room temperature, and all light unit (LU) data were obtained from the average of 2 separate experiments and corrected for background protein A/G bead binding [12] groups was highly significant ( ). The patients with PEL P ! .001 had high anti-LANA antibody titers, which were not significantly different from those in the patients with KS ( ). P p .87 Using a cut-off derived from the uninfected control subjects ( Figure 1C 
/KS
Ϫ patients ( Figure   1D ). As shown in Figure 1D , significant differences were found between the sum of the anti- Figure 1D ). Although this 70,000 LU cut-off was less useful in discriminating patients with KS from MCD + /KS + patients (64% sensitivity and 91% specificity), a higher cut-off of 165,000 LU demonstrated 93% sensitivity (13 of 14 of the MCD + /KS + patients were below the cut-off) and 83% specificity for distinguishing patients with KS from MCD + /KS + patients ( Figure 1D ). By profiling antibodies against several latent and lytic human herpesvirus 8 antigens, significant differences in antibody titers were observed between the patients with KS, MCD, and PEL. One of the most obvious differences was that antibody titers against the early lytic human herpesvirus 8 antigen, K8.1, were markedly higher in the patients with PEL and MCD, compared with the patients with KS. The findings of higher anti-K8.1 antibody levels in patients with MCD are consistent with studies showing that a substantial percentage of MCD cells express lytic KSHV genes, including a virally encoded IL-6. Similarly, the higher antibody titers against the ORF65 lytic protein in patients with PEL, compared with patients with KS, may also reflect the greater KSHV load and expression of lytic antigens in patients with PEL [9, 13] . It is not clear why antibodies to another lytic antigen, ORF65, were not significantly higher in patients with MCD than in those with KS. It is possible that it relates to ORF65 being a late lytic antigen. Alternatively, it is possible that this occurs, in part, because patients with MCD have some subtle defects in specific antibody production, per-haps related to cytokine dysregulation that blunts what would otherwise be an increase.
In contrast to the anti-K8.1 antibody profile, markedly higher levels of antibody to v-cyclin, a latent KSHV gene, were found in the patients with KS and PEL, compared with those with MCD. Anti-LANA antibody titers also were also markedly higher in the patients with KS, compared those with MCD. Together these results are consistent with immunohistochemical studies demonstrating that KS spindle cells express large amounts of latent human herpesvirus 8 proteins, compared with MCD cells [9, 10, 14] 
